Literature DB >> 3837506

Hemodialyzer reuse: practices in the United States and implication for infection control.

L Bland, M Alter, M Favero, L Carson, L Cusick.   

Abstract

Reuse of hemodialyzers has continued to increase dramatically. In 1983, 52% of the hemodialysis centers were reusing hemodialyzers. Use of hollow fiber hemodialyzers has paralleled this increase in hemodialyzer reuse with 63% of the hemodialysis centers reporting exclusive use of this type of hemodialyzer in 1983. Although reuse of hemodialyzers has not been associated with increased incidence of hepatitis B infection or pyrogenic reactions, an outbreak of nontuberculous mycobacteria in 27 chronic hemodialysis patients was probably associated with water used to reprocess dialyzers. Nontuberculous mycobacteria were isolated from the water in 83% of 115 hemodialysis centers surveyed across the United States and could constitute a potential infection risk because of the organisms' greater germicide resistance than most other naturally occurring water bacteria. Two percent formaldehyde is not an effective germicide for high level disinfection of hemodialyzers. Reprocessed hemodialyzers should be disinfected with 4% formaldehyde or an equivalent disinfectant.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3837506

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN: 0066-0078


  3 in total

1.  Efficacy of chemical dosing methods for isolating nontuberculous mycobacteria from water supplies of dialysis centers.

Authors:  L A Carson; L B Cusick; L A Bland; M S Favero
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

2.  Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers.

Authors:  L A Carson; L A Bland; L B Cusick; M S Favero; G A Bolan; A L Reingold; R C Good
Journal:  Appl Environ Microbiol       Date:  1988-12       Impact factor: 4.792

3.  The reuse of hemodialyzers: an assessment of safety and potential savings.

Authors:  E Baris; M McGregor
Journal:  CMAJ       Date:  1993-01-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.